Literature DB >> 20682279

Aggregation modulating elements in mutant human superoxide dismutase 1.

Celeste M Karch1, David R Borchelt.   

Abstract

Mutations in superoxide dismutase 1 (SOD1) cause some forms of familial amyotrophic lateral sclerosis (fALS). Affected tissues of patients and transgenic mouse models of the disease accumulate misfolded and aggregated forms of the mutant protein. In the present study we have identified specific sequences in human SOD1 that modulate the aggregation of fALS mutant proteins. From our study of a panel of mutant proteins, we identify two sequence elements in human SOD1 (residues 42-50 and 109-123) that are critical in modulating the aggregation of the protein. These sequences are components of the 4th and 7th β-strands of the protein, and in the native structure are normally juxtaposed as elements of the core β-barrel. Our data suggest that some type of intermolecular interaction between these elements may occur in promoting mutant SOD1 aggregation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682279      PMCID: PMC2997613          DOI: 10.1016/j.abb.2010.07.027

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  35 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

Authors:  J A Johnston; M J Dalton; M E Gurney; R R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

3.  Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction.

Authors:  Ashutosh Tiwari; Lawrence J Hayward
Journal:  J Biol Chem       Date:  2002-11-27       Impact factor: 5.157

4.  Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.

Authors:  Lawrence J Hayward; Jorge A Rodriguez; Ji W Kim; Ashutosh Tiwari; Joy J Goto; Diane E Cabelli; Joan Selverstone Valentine; Robert H Brown
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

Review 5.  The perplexing role of copper-zinc superoxide dismutase in amyotrophic lateral sclerosis (Lou Gehrig's disease).

Authors:  Soshanna Zittin Potter; Joan Selverstone Valentine
Journal:  J Biol Inorg Chem       Date:  2003-03-19       Impact factor: 3.358

6.  Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature.

Authors:  Jiou Wang; Hilda Slunt; Victoria Gonzales; David Fromholt; Michael Coonfield; Neal G Copeland; Nancy A Jenkins; David R Borchelt
Journal:  Hum Mol Genet       Date:  2003-09-09       Impact factor: 6.150

7.  Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS.

Authors:  Jennifer Stine Elam; Alexander B Taylor; Richard Strange; Svetlana Antonyuk; Peter A Doucette; Jorge A Rodriguez; S Samar Hasnain; Lawrence J Hayward; Joan Selverstone Valentine; Todd O Yeates; P John Hart
Journal:  Nat Struct Biol       Date:  2003-06

8.  Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.

Authors:  P Andreas Jonsson; Karin Ernhill; Peter M Andersen; Daniel Bergemalm; Thomas Brännström; Ole Gredal; Peter Nilsson; Stefan L Marklund
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

Review 9.  Misfolded CuZnSOD and amyotrophic lateral sclerosis.

Authors:  Joan Selverstone Valentine; P John Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

10.  Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.

Authors:  Mercedes Prudencio; P John Hart; David R Borchelt; Peter M Andersen
Journal:  Hum Mol Genet       Date:  2009-05-30       Impact factor: 6.150

View more
  13 in total

1.  AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.

Authors:  Marcel F Leyton-Jaimes; Joy Kahn; Adrian Israelson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

2.  Solid-state NMR studies of metal-free SOD1 fibrillar structures.

Authors:  Lucia Banci; Olga Blaževitš; Francesca Cantini; Jens Danielsson; Lisa Lang; Claudio Luchinat; Jiafei Mao; Mikael Oliveberg; Enrico Ravera
Journal:  J Biol Inorg Chem       Date:  2014-04-10       Impact factor: 3.358

3.  Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models.

Authors:  Jacob I Ayers; Benjamin McMahon; Sabrina Gill; Herman L Lelie; Susan Fromholt; Hilda Brown; Joan Selverstone Valentine; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2016-11-25       Impact factor: 5.372

4.  Abnormal SDS-PAGE migration of cytosolic proteins can identify domains and mechanisms that control surfactant binding.

Authors:  Yunhua Shi; Richard A Mowery; Jonathan Ashley; Michelle Hentz; Alejandro J Ramirez; Basar Bilgicer; Hilda Slunt-Brown; David R Borchelt; Bryan F Shaw
Journal:  Protein Sci       Date:  2012-08       Impact factor: 6.725

5.  Fibrillation precursor of superoxide dismutase 1 revealed by gradual tuning of the protein-folding equilibrium.

Authors:  Lisa Lang; Martin Kurnik; Jens Danielsson; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-13       Impact factor: 11.205

Review 6.  SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.

Authors:  Peter I Joyce; Pietro Fratta; Elizabeth M C Fisher; Abraham Acevedo-Arozena
Journal:  Mamm Genome       Date:  2011-06-26       Impact factor: 2.957

Review 7.  Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.

Authors:  Aurélie de Rus Jacquet; Hélèna L Denis; Francesca Cicchetti; Melanie Alpaugh
Journal:  Mol Psychiatry       Date:  2021-01-25       Impact factor: 13.437

8.  An analysis of interactions between fluorescently-tagged mutant and wild-type SOD1 in intracellular inclusions.

Authors:  David A Qualls; Keith Crosby; Hilda Brown; David R Borchelt
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

9.  Role of disulfide cross-linking of mutant SOD1 in the formation of inclusion-body-like structures.

Authors:  Brittany L T Roberts; Kinaree Patel; Hilda H Brown; David R Borchelt
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.

Authors:  Jacob I Ayers; Guilian Xu; Olga Pletnikova; Juan C Troncoso; P John Hart; David R Borchelt
Journal:  Acta Neuropathol Commun       Date:  2014-05-14       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.